Clinical trial
Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma…
NCT00181025 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Unknown status
Key facts
| NCT number | NCT00181025 |
|---|---|
| Title | Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle |
| Official title | Isolated Pelvic and Limb Perfusion With 1mg TNFa in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma of Pelvis |
| Intervention type | Drug |
| Interventions | Tasonermine (TNFa), Melphalan |
| Enrollment | 33 |
| Start date | May 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 12, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: